Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Moudgal, Varsha, Little, Tania, Boikov, Dina, Vazquez, Jose A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2005
Gaiak:
Clinical Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC547225/
https://ncbi.nlm.nih.gov/pubmed/15673762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.2.767-769.2005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak